HIV Vaccine Awareness Day 2019 falls on the cusp of a scientific breakthrough.
A new report issued at this year's HIVR4P conference states that flat and/or reduced funding for HIV/AIDS and other global health issues threatens to roll back progress worldwide.
The effectiveness of pre-exposure prophylaxis has played a role in diverting U.S. funding from microbicide research.
A new HIV vaccine candidate has shown over 50% effectiveness in preventing transmission of an HIV-like virus in monkeys, according to a recent animal study.
May 18 marks the 20th anniversary of HIV Vaccine Awareness Day. AVAC is celebrating by hosting a series of webinars to discuss key issues in vaccine research and advocacy.